CID 510383

Moxifloxacin impurity 20

Structural Information

Molecular Formula
C21H25N3O4
SMILES
COC1=C(C=CC2=C1N(C=C(C2=O)C(=O)O)C3CC3)N4C[C@@H]5CCCN[C@@H]5C4
InChI
InChI=1S/C21H25N3O4/c1-28-20-17(23-9-12-3-2-8-22-16(12)11-23)7-6-14-18(20)24(13-4-5-13)10-15(19(14)25)21(26)27/h6-7,10,12-13,16,22H,2-5,8-9,11H2,1H3,(H,26,27)/t12-,16+/m0/s1
InChIKey
BHEIRUWTKHGJOV-BLLLJJGKSA-N
Compound name
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-8-methoxy-4-oxoquinoline-3-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

6
Patents

383.1845 Da
Monoisotopic Mass

0.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 384.19178 196.6
[M+Na]+ 406.17372 204.5
[M-H]- 382.17722 201.2
[M+NH4]+ 401.21832 201.8
[M+K]+ 422.14766 196.6
[M+H-H2O]+ 366.18176 187.8
[M+HCOO]- 428.18270 206.2
[M+CH3COO]- 442.19835 203.4
[M+Na-2H]- 404.15917 193.7
[M]+ 383.18395 195.7
[M]- 383.18505 195.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe